Cantor Fitzgerald Reiterates Overweight Rating on Insmed (INSM) Ahead of Q2 Results

Go back to Cantor Fitzgerald Reiterates Overweight Rating on Insmed (INSM) Ahead of Q2 Results
INSMED (NASDAQ: INSM) Delayed: 132.28 -0.29 (0.22%)
Previous Close $132.57    52 Week High $19.30 
Open $132.31    52 Week Low $9.02 
Day High $135.26    P/E N/A 
Day Low $130.80    EPS $-1.69 
Volume 1,563,224